Rojanasakul et al., Antisense oligonucleotidde therapeutics: drug delivery and targeting, Advanced Drug Delivery Reviews, vol. 18, pp. 115-131, 1996.* |
Gewirtz et al., Facilitating oligonucleotide delivery: helping antisense deliver on its promise, Proc. Natl. Acad. Sci., vol. 93, pp. 3161-3163, Apr. 1996.* |
Branch, A good antisense molecule is hard to find, TIBS, vol. 23, pp. 45-50, Feb. 1998.* |
Crooke et al., Basic Principles of Antisense Therapeutics, Antisense Research and Application, pp. 1-50, Jul. 7, 1998.* |
Hochman and Artursson, “Mechanisms of absorption enhancement and tight junction regulation” Journal of Controlled Release 29, 253-267 (1994). |
Kevil C. G., et al., “Expression of zonula occludens and adherens juctional proteins in human venous and arterial endothelial cells: role of occludin in endothelial solute barriers” Microcirculation 5(2-3) 197-210 (1998). |
Ismael J. Hidalgo et al, “Characterization of the Human Colon Carcinoma Cell Line (Caco-2) as a Model Systems for Intestinal Epithelial Permeability” Gastroenterology 96:736-49 (1989). |
Pierre H. Vachon et al., “Transient Mosaic Patterns of Morphological and Functional Differentiation in the Caco-2 Cell Line” Gastroenterology 103:414-423 (1992). |
Wong V., et al., “A Synthetic Peptide Corresponding to the Extraacellular Domain of Occludin Perturbs the Tight Junction Permeability Barrier”, The Journal of Cell Biology, vol. 136, No. 2, Jan. 27, 1997 399-409. |
Furuse M., et al., “Occludin: A Novel Intergral Membrane Protein Localizing at Tight Juctions”, The Journal of Cell Biology, vol. 123, No. 6, Part 2, Dec. 1993 1777-1780. |
Ando-Akatsuka Y., et al., Interspecies Diversity of the Occluding Sequence: cDNA Cloning of Human, Mouse, Dog, and Rat-Kangaroo Homologues, The Journal of Cell Biology. vol. 133, No. 1, Apr. 1996 43-47. |
Furuse, M., et al. “Direct Association of Occludin with ZO-1 and its Possible Involvement in the Localization of Occludin at Tight Junctions”, The Journal of Cell Biology, vol. 127, No. 6, Dec. 1994 1617-1626. |